Molecular Pathology Laboratory Network
Healthcare Services · Tennessee, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
250 E Broadway Ave, Maryville, Tennessee...Phone Number
(865) 380-9746Website
www.mplnet.comRevenue
$20.1 MillionIndustry
ZI Rank: 4
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
2
2
4
3
4
About Molecular Pathology Laboratory Network
Molecular Pathology Laboratory Network, Inc. (MPLN) is a leader in laboratory medicine, specializing in hematopathology, solid tumor oncology, immunology, and women's health. Established in 1989, MPLN has pioneered molecular pathology techniques for diagnostic and clinical research applications. The company offers a comprehensive range of testing services, including genomic solutions, digital pathology, and cytogenetics, aimed at enhancing patient care and supporting clinical trials. MPLN serves biopharma clients and healthcare providers, delivering high-quality data and exceptional customer service.Explore more
Molecular Pathology Laboratory Network Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Molecular Pathology Laboratory Network your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Molecular Pathology Laboratory Network recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Molecular Pathology Laboratory Network had a recent Job posting/layoffs
Product Launch: Get notified when Molecular Pathology Laboratory Network launches new products
Funding: Get notified immidiatlly once Molecular Pathology Laboratory Network has new funding data
Molecular Pathology Laboratory Network, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Molecular Pathology Laboratory Network is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Molecular Pathology Laboratory Network
Check if Molecular Pathology Laboratory Network has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Molecular Pathology Laboratory Network as Masked Content
Find 2 more new buyers
Compare Similar Companies to Molecular Pathology Laboratory Network
Compare insights from companies similar to Molecular Pathology Laboratory Network, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$7M
51-200
Private
$40.8M
2007
MS
Maithreyan SrinivasanTechnology Senior Director, Research & Development
Company Profile Activity
Activity Insights
Molecular Pathology Laboratory Network is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Molecular Pathology Laboratory Network is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Molecular Pathology Laboratory Network.
Molecular Pathology Laboratory Network financials insights
Gather financial insights about Molecular Pathology Laboratory Network, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
2021
Debt
$708K
Molecular Pathology Laboratory Network Tech Stack
A closer look at the technologies used by Molecular Pathology Laboratory Network
Most Recent Scoops
Open Position
Open Position
Funding
Molecular Pathology Laboratory Network has received an SBA PPP loan in the amount of $708,248 from Home Federal Bank of Tennessee resulting in the retention of 57 jobs.
Funding
Molecular Pathology Laboratory Network News & Media
MultiPlan Corporation (MPLN) CEO Dale White on Q2 2022 Results - Earnings Call Transcript
MultiPlan Corporation (NYSE:NYSE:MPLN) Q2 2022 Earnings Conference Call August 4, 2022 10:00 ET Company Participants Shawna Gasik - Investor Relations Dale White - Chief Executive Officer...DEADLINE ALERT for IMVT, EBIX, APA, and MPLN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
LOS ANGELES, April 19, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Read more news
Top Healthcare Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Molecular Pathology Laboratory Network
Sign Up For FreeTo access detailed company insights
Molecular Pathology Laboratory Network, Inc. (MPLN) is a leader in laboratory medicine, specializing in hematopathology, solid tumor oncology, immunology, and women's health. Established in 1989, MPLN has pioneered molecular pathology techniques for diagnostic and clinical research applications. The company offers a comprehensive range of testing s... Read More
